← Back to Search

Self-compassionate writing intervention for Distress Intolerance

N/A
Waitlist Available
Led By Allison Kelly, PhD
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention (assessed as a mediator)
Awards & highlights

Study Summary

Perceived emotional distress intolerance is a transdiagnostic marker of psychopathology associated with psychological and interpersonal dysfunction, and the development of interventions for perceived emotional distress intolerance is of prime importance. One potential intervention is a behavioural experiment, i.e. a cognitive behaviour therapy technique where clients undergo an exercise designed to test a maladaptive belief, e.g., that negative emotions are unbearable, and adjust their belief to accommodate any disconfirmatory information that arises through the exercise. This study examines the effects of a one-session self-compassion writing behavioural experiment compared to a one-session expressive writing behavioural experiment on low perceived distress tolerance. Participants were recruited from the University of Waterloo and Prolific, and were randomly assigned to the self-compassion condition, expressive writing condition, or a control condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to one week post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to one week post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compassionate Engagement and Action Scale
Distress Tolerance Scale
Distress Tolerance Scale (short form)
+1 more
Secondary outcome measures
Soothing affect measures (researcher-generated) - Adapted from the Serenity Subscale of the PANAS-X and the Safe/Warmth Positive Affect Subscale of the Types of Positive Affect Scale (TPAS)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Self-compassionate writing interventionExperimental Treatment1 Intervention
Participants assigned to this intervention were asked to engage in one brief online self-compassionate writing session, where they were asked to write about and experience their feelings from the perspective of an inner compassionate observer.
Group II: Expressive writing interventionExperimental Treatment1 Intervention
Participants assigned to this intervention were asked to engage in one brief online expressive writing session, where they were asked to explore their deepest thoughts and emotions surrounding an upsetting situation through writing.
Group III: Control writing taskActive Control1 Intervention
Participants assigned to this condition were asked to engage in a neutral time management writing task.

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
123 Previous Clinical Trials
209,354 Total Patients Enrolled
Allison Kelly, PhDPrincipal InvestigatorAssociate professor
2 Previous Clinical Trials
460 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~113 spots leftby Apr 2025